1-2 of 2
Maureen M. Okam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea

Maureen M. Okam, Erica B. Esrick, Elyse Mandell, Federico Campigotto, Donna S. Neuberg, Benjamin L. Ebert
Journal: Blood
Blood (2015) 125 (23): 3668–3669.
https://doi.org/10.1182/blood-2015-03-635391
Published: 2015
Journal Articles

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Clinical Trials & Observations
Joshua J. Field, Gene Lin, Maureen M. Okam, Elaine Majerus, Jeffrey Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan
Journal: Blood
Blood (2013) 121 (17): 3329–3334.
https://doi.org/10.1182/blood-2012-11-465963
Published: 2013
Includes: Supplemental data